How to commercialize a new strain as a probiotic

Johanna will be talking about the path that is needed to commercialize a new strain as a probiotic. Starting from isolation of the strain from e.g.a clinical study, through strain characterization and safety assessments to move forward with manufacturing optimization, while also looking at the health efficacy potential from preclinical studies to human clinicals.